V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 180007114 | 180003841 | null | null | null | null | 2020-05-10 | CABOZANTINIB | null | null | CISPLATIN | 101822671 |
| 180007867 | 180003850 | null | null | null | 2019-07-19 | 2019-07-19 | CABOZANTINIB | null | null | TRIAL UNSPECIFIED | 101807444 |
| 180008286 | 180003855 | null | null | null | null | 2017-07-29 | null | null | null | CISPLATIN + PEMETREXED | 101688440 |
| 180008622 | 180003862 | null | null | null | null | 2021-12-18 | CABOZANTINIB | null | null | CNS MEDBL HR CISPLATIN/VINCRISTINE/CYCLOPHOSPHAMIDE | 101783556 |
| 180008824 | 180003866 | null | null | null | 2016-11-13 | 2016-11-19 | IBRUTINIB | 02 | null | CYCLOPHOSPHAMIDE + FLUDARABINE | 100891060 |
| 180009056 | 180003867 | null | null | null | 2014-11-19 | 2015-03-18 | Trial Unspecified | null | null | TRIAL UNSPECIFIED | 100060442 |
| 180009346 | 180003872 | null | null | null | null | 2019-08-18 | Oxaliplatin + Modified de Gramont | null | null | CARBOPLATIN + PEMETREXED | 100063118 |
| 180009564 | 180003874 | null | null | null | null | 2017-05-19 | FEC 100 | null | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100843376 |
| 180009623 | 180003875 | 0 | null | null | 2018-08-04 | 2019-06-29 | null | null | null | NB HRNBL-1 ISOTRETINOIN | 100674591 |
| 180010022 | 180003881 | null | null | null | null | 2019-03-18 | VANDETANIB | null | null | CAPECITABINE + OXALIPLATIN | 101373516 |
| 180010965 | 180003895 | null | null | null | null | 2019-11-22 | NB Rel CCLG guidelines Irin & Temoz | null | null | CABOZANTINIB | 100258032 |
| 180011121 | 180003897 | null | null | null | null | 2017-08-07 | LENVATINIB | null | null | FLUOROURACIL + OXALIPLATIN | 101829990 |
| 180011350 | 180003899 | 1.75 | null | null | null | 2017-12-14 | NB HRNBL-1 BUMEL MAT | null | null | NOT MATCHED | 100095994 |
| 180011471 | 180003902 | null | null | null | null | 2016-10-25 | Antibody NBL | null | null | CISPLATIN + PACLITAXEL | 101802180 |
| 180012028 | 180003907 | null | null | null | null | 2017-08-22 | null | null | null | NB RELAPSED CYCLOPHOSPHAMIDE AND TOPOTECAN | 101510187 |
| 180012063 | 180003910 | null | null | null | 2019-11-28 | 2020-10-14 | PEMBROLIZUMAB | 02 | null | MITOTANE | 101472984 |
| 180012140 | 180003913 | null | null | null | 2020-02-05 | 2020-02-13 | NB HRNBL-1 COJEC Ind COURSE B | null | null | LENVATINIB | 101195072 |
| 180012155 | 180003914 | null | null | null | null | 2016-12-11 | FLUOROURACIL + OXALIPLATIN | null | null | PACKER MAINTENANCE | 100361650 |
| 180012205 | 180003915 | null | null | null | 2018-10-20 | 2019-07-26 | null | null | null | NB HRNBL-1 COJEC IND COURSE C | 100400920 |
| 180012276 | 180003916 | null | null | null | 2021-08-18 | 2022-02-21 | ETOPOSIDE | null | null | NOT MATCHED | 101017820 |
| 180012640 | 180003922 | null | null | null | null | 2021-10-23 | Trial Unspecified | null | null | NOT MATCHED | 101299721 |
| 180012941 | 180003924 | null | null | null | null | 2019-07-20 | Carboplatin + Paclitaxel (3 weekly) | N | null | NB HRNBL-1 BUMEL MAT | 100218966 |
| 180012962 | 180003925 | null | null | null | 2020-05-10 | 2020-05-22 | ETOPOSIDE | null | null | TEMOZOLOMIDE | 101031646 |
| 180013089 | 180003927 | 1.1 | null | null | 2019-12-12 | 2020-09-08 | ABEMACICLIB + FULVESTRANT | null | null | DABRAFENIB + TRAMETINIB | 100101985 |
| 180013161 | 180003930 | null | null | null | null | 2019-07-23 | Trial Unspecified | null | null | TEMOZOLOMIDE | 100544387 |
| 180013174 | 180003931 | null | null | null | null | 2020-07-04 | VANDETANIB | null | null | CISPLATIN + DOXORUBICIN + ETOPOSIDE | 101256526 |
| 180013331 | 180003933 | null | null | null | null | 2017-01-16 | NB HRNBL-1 ch14.18/CHO(trial) +IL-2 | null | null | NOT MATCHED | 101738709 |
| 180000404 | 180003937 | null | null | null | 2021-07-03 | 2021-07-06 | Capecitabine 42days + RT | null | null | LENVATINIB | 100480276 |
| 180004053 | 180003941 | null | null | null | 2020-12-12 | 2022-01-25 | CAPECITABINE + OXALIPLATIN | null | null | DABRAFENIB + TRAMETINIB | 101226306 |
| 180007170 | 180003944 | null | null | null | 2022-03-19 | 2022-03-19 | NB Low/Interm risk guidelines Carbo/Etop | null | null | DINUTUXIMAB BETA | 101811280 |
| 180010000 | 180003949 | null | null | null | 2020-08-25 | 2020-09-01 | Niraparib | null | null | NB HRNBL-1 ISOTRETINOIN | 101820973 |
| 180012294 | 180003953 | null | null | null | 2018-01-01 | 2020-02-23 | Dinutuximab Beta | null | null | NB HRNBL-1 ISOTRETINOIN | 100332877 |
| 180012631 | 180003956 | null | null | null | null | 2021-04-18 | NB HRNBL-1 BUMEL MAT | null | null | NB HRNBL-1 BUMEL MAT | 100235110 |
| 180000098 | 180003958 | 0 | null | null | null | 2019-04-02 | NB BEACON Temozolomide Topotecan | null | null | CISPLATIN + DOXORUBICIN + ETOPOSIDE + MITOTANE | 101425257 |
| 180001352 | 180003962 | null | null | null | 2021-07-04 | 2022-05-12 | CABOZANTINIB | null | null | CARBOPLATIN + GEMCITABINE | 101781777 |
| 180001382 | 180003963 | null | null | null | 2018-11-21 | 2018-12-11 | Cyclophosphamide + Vincristine | null | null | CARBOPLATIN | 100480694 |
| 180001453 | 180003964 | null | null | null | null | 2020-10-27 | NB 13 cis-RA (Isotretinoin) | null | null | NB HRNBL-1 COJEC IND COURSE A | 100251538 |
| 180001855 | 180003970 | null | null | null | 2021-01-05 | 2021-04-22 | NB HRNBL-1 ch14.18/CHO only (trial) | null | null | NB HRNBL-1 ISOTRETINOIN | 100849373 |
| 180003150 | 180003974 | 1.55 | null | null | 2017-11-14 | 2017-11-19 | Methotrexate High Dose (3g/m2) | null | null | CABOZANTINIB | 100759506 |
| 180003626 | 180003985 | null | null | null | null | 2018-02-03 | AFATINIB | null | null | TEMOZOLOMIDE | 101401458 |
| 180003840 | 180003990 | null | null | null | 2020-02-10 | 2020-02-11 | NB HRNBL-1 COJEC Ind COURSE B | null | null | PACKER MAINTENANCE | 100441558 |
| 180004076 | 180003994 | 1.64 | null | null | null | 2021-04-14 | NB HRNBL-1 Isotretinoin | null | null | CNS GCT II | 100554776 |
| 180004175 | 180003995 | null | null | null | 2022-02-05 | 2022-02-15 | CARBOPLATIN + ETOPOSIDE | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100445875 |
| 180004777 | 180004002 | null | null | null | null | 2021-02-15 | SELPERCATINIB | null | null | TOPOTECAN | 101052062 |
| 180004880 | 180004004 | null | null | null | 2021-08-23 | 2021-09-06 | NB HRNBL-1 Isotretinoin | null | null | CISPLATIN + DOXORUBICIN + ETOPOSIDE | 100312563 |
| 180004943 | 180004005 | null | null | null | null | 2018-10-04 | GEFITINIB | null | null | CAPECITABINE | 100113751 |
| 180005790 | 180004012 | null | null | null | null | 2018-09-06 | NB HRNBL-1 ch14.18/CHO(trial) +IL-2 | null | null | NB HRNBL-1 ISOTRETINOIN | 101587585 |
| 180005800 | 180004013 | null | null | null | null | 2018-07-06 | NIVOLUMAB | null | null | TEMOZOLOMIDE | 101625425 |
| 180005817 | 180004014 | null | null | null | 2021-12-03 | 2021-12-21 | Cyclophosphamide oral | null | null | CAPECITABINE + OXALIPLATIN | 101415269 |
| 180006136 | 180004016 | null | null | null | 2018-10-10 | 2019-02-06 | Sorafenib | null | null | NB HRNBL-1 ISOTRETINOIN | 100012883 |